Back
MAX S&P 500 4X Leveraged ETN Vs. Verona Pharma PLC Industry Stock Comparison
Buy
58
SPYU
MAX S&P 500 4X Leveraged ETN
Last Price:
$52.04
Seasonality Move:
--
Sell
48
VRNA
Verona Pharma PLC
Last Price:
$45.02
Seasonality Move:
1.28%
Buy
58
MAX S&P 500 4X Leveraged ETN (SPYU)
is a Buy
Is MAX S&P 500 4X Leveraged ETN a Buy, Sell or Hold?
-
The current MAX S&P 500 4X Leveraged ETN [SPYU] share price is $51.97. The Score for SPYU is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
-
SPYU is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
48
Verona Pharma PLC (VRNA)
is a Sell
Is Verona Pharma PLC a Buy, Sell or Hold?
-
The current Verona Pharma PLC [VRNA] share price is $45.04. The Score for VRNA is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
VRNA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SPYU Stock Price Chart
What is MAX S&P 500 4X Leveraged ETN's stock price today?
-
The MAX S&P 500 4X Leveraged ETN share price today is $51.97Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SPYU is experiencing buying pressure, which is a positive indicator for future bullish movement.
VRNA Stock Price Chart
What is Verona Pharma PLC's stock price today?
-
The Verona Pharma PLC share price today is $45.04Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VRNA is experiencing slight selling pressure.
SPYU Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.14 | Sell |
| Relative Strength Index (14 RSI): | 51.62 | Buy |
| Chaikin Money Flow: | 367863 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (49.73 - 54.49) | Sell |
| Bollinger Bands (100): | (41.15 - 51.71) | Buy |
VRNA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.65 | Buy |
| Relative Strength Index (14 RSI): | 68.18 | Buy |
| Chaikin Money Flow: | -67723 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (38.54 - 42.18) | Buy |
| Bollinger Bands (100): | (26.89 - 38.85) | Buy |
SPYU Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 51.07 | Buy |
| 20-day SMA: | 52.62 | Sell |
| 50-day SMA: | 50.42 | Buy |
| 200-day SMA: | 42.67 | Buy |
| 8-day EMA: | 50.8 | Buy |
| 20-day EMA: | 51.54 | Buy |
| 50-day EMA: | 50.21 | Buy |
| 200-day EMA: | 22.85 | Buy |
VRNA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 42.43 | Buy |
| 20-day SMA: | 40.79 | Buy |
| 50-day SMA: | 38.03 | Buy |
| 200-day SMA: | 24.5 | Buy |
| 8-day EMA: | 42.68 | Buy |
| 20-day EMA: | 40.99 | Buy |
| 50-day EMA: | 37.9 | Buy |
| 200-day EMA: | 27.99 | Buy |
MAX S&P 500 4X Leveraged ETN Earnings Growth & SPYU Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Verona Pharma PLC Earnings Growth & VRNA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.32 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.73 per share, and an increase next year of $1.40 per share.
MAX S&P 500 4X Leveraged ETN Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Verona Pharma PLC Technical Analysis
| Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||